Company Filing History:
Years Active: 2022
Title: Amy Easton: Innovator in Neurological Treatments
Introduction
Amy Easton is a prominent inventor based in South San Francisco, California. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic solutions for neurological disorders. Her innovative work has garnered attention in the scientific community.
Latest Patents
Amy Easton holds a patent for "Oligonucleotides for modulating TMEM106B expression." This invention relates to oligonucleotides that are complementary to and modulate the expression of TMEM106B. The patent further encompasses conjugates of the oligonucleotide and pharmaceutical compositions, along with methods for treating neurological disorders using the oligonucleotide.
Career Highlights
Easton is currently employed at Genentech, Inc., a leading biotechnology company known for its focus on innovative medicines. Her work at Genentech has allowed her to collaborate with other talented professionals in the field.
Collaborations
Some of her notable coworkers include Peter Hagedorn and Marianne Lerbech Jensen. Their collective expertise contributes to the advancement of research and development in biotechnology.
Conclusion
Amy Easton's contributions to the field of biotechnology, particularly through her patent on oligonucleotides, highlight her role as an innovator in developing treatments for neurological disorders. Her work continues to inspire advancements in medical science.